Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-004137
Filing Date
2021-11-10
Accepted
2021-11-10 16:41:11
Documents
63
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q imgo-20210930.htm   iXBRL 10-Q 2848872
2 EX-10.1 imgo-ex10_1.htm EX-10.1 91353
3 EX-31.1 imgo-ex31_1.htm EX-31.1 30558
4 EX-31.2 imgo-ex31_2.htm EX-31.2 30417
5 EX-32.1 imgo-ex32_1.htm EX-32.1 20234
  Complete submission text file 0000950170-21-004137.txt   8728820

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imgo-20210930.xsd EX-101.SCH 40304
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imgo-20210930_cal.xml EX-101.CAL 33872
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imgo-20210930_lab.xml EX-101.LAB 379953
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imgo-20210930_def.xml EX-101.DEF 210260
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imgo-20210930_pre.xml EX-101.PRE 298115
11 EXTRACTED XBRL INSTANCE DOCUMENT imgo-20210930_htm.xml XML 1510780
Mailing Address 329 OYSTER POINT BLVD., 3RD FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 329 OYSTER POINT BLVD., 3RD FLOOR SOUTH SAN FRANCISCO CA 94080 650 325 5156
Imago BioSciences, Inc. (Filer) CIK: 0001623715 (see all company filings)

EIN.: 454915810 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40604 | Film No.: 211397371
SIC: 2834 Pharmaceutical Preparations